In this regard, NDRG1 inhibited TGFβ (transforming growth factor β)-induced Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT) in colon and prostate cancer cells 19. Here, NDRG1 is linked to prostate cancer.